Weakening FDA’s Authority Over Tobacco Could Impact Use, Advocates Say
Weakening the Food and Drug Administration’s regulatory authority over tobacco could have an adverse impact on tobacco use, according to advocacy groups.
The National Business Coalition on Health (NBCH) has cited smoking-prevention programs as one of the most cost-effective ways for employers to cut their healthcare costs.
The NBCH’s eValue8 healthcare performance-evaluation tool found that 80 percent of health plans “are adopting evidence-based benefit design and are incorporating counseling and the use of FDA-approved medication with positive results,” according to Dennis White, senior vice president for value-based purchasing at the group.
About half of the health plans assessed by NBCH for their tobacco-cessation programs scored 50 percent or better, with 17 percent scoring 75 percent or better on the 100-point eValue8 scale.
The NBCH is a nonprofit whose members include about 60 employer-based healthcare coalitions and is dedicated to value-based purchasing of healthcare services.